WLRN2h
Study: Young people at higher risk for Type 2 diabetes after COVID
Young people 10 to 19 years old are 1.5 times more likely to be diagnosed with Type 2 diabetes in the six months after having COVID-19.
PipelineReview.com6h
Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial
BAGSVAERD, Denmark I1, 2024 I Novo Nordisk today announced the headline results from the SOUL cardiovascular outcomes trial. The double-blinded, ...
EuropaWire11h
Novo Nordisk’s Oral Semaglutide Reduces Cardiovascular Risk by 14% in Type 2 Diabetes Patients, SOUL Trial Shows
(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events ...
Today's Dietitian magazine12h
Replacing Ultraprocessed Foods in Diet Reduces Type 2 Diabetes Risk
People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, finds a new study led by ...
The ‘C’ and ‘D’ of diabetes
Early control of HbA1c levels and weight in people with diabetes significantly reduces cardiac disease risk. Delays in ...
The ‘A’ and ‘B’ of diabetes: When less is more
HbA1c testing is crucial for diabetes management as it reflects average blood sugar levels over three months, unlike ...
Zawya13h
Killer diseases put focus on Kenya’s health care
Cancer, malaria and pneumonia continue to be some of Kenya’s biggest health challenges despite the scale-up of intervention tools, and that is expected to be the case in coming years.